Phosphorylation of TRAF2 within its RING domain inhibits stress-induced cell death by promoting IKK and suppressing JNK activation

Cancer Research

Volumn 69, Issue 8, 2009, Pages 3665-3672

  Thomas, Gregory S ^a   Zhang, Laiqun ^a   Blackwell, Ken ^a   Habelhah, Hasem ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE C ZETA; SERINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL STRESS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; HODGKIN DISEASE; HUMAN; HUMAN CELL; LYMPHOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RING FINGER MOTIF;

ANIMALS; APOPTOSIS; ENZYME ACTIVATION; HELA CELLS; HUMANS; I-KAPPA B KINASE; MAP KINASE KINASE 4; MICE; NIH 3T3 CELLS; PHOSPHORYLATION; RING FINGER DOMAINS; TNF RECEPTOR-ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65949114424     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4867     Document Type: Article

References (26)

1. Bradley JK, Pober JS. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 2001; 20: 6482-91. (Pubitemid 32977853)
2. Wajant H, Henkler F, Scheurich P. The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal 2001; 13: 389-400. (Pubitemid 32510989)
3. Bonizzi G, Karin M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004; 25: 280-8. (Pubitemid 38610351)
4. Karin M, Cao Y, Greten FR, Li ZW. NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2002; 2: 301-10. (Pubitemid 37328783)
5. Greten FR, Eckmarm L, Greten TF. et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285-96. (Pubitemid 39061110)
6. Aggarwal BB. Nuclear factor-KB: the enemy within. Cancer Cell 2004; 6: 203-8.
7. Orlowski RZ, Baldwin AS, Jr. NF-κB as a therapeutic target in cancer. Trends Mol. Med 2002; 8: 385-9.
8. Yeh WC, Shahmian A, Speiser D. et al. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 1997; 7: 715-25. (Pubitemid 28156638)
9. Tada K, Okazaki T, Sakon S. et al. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-κB activation and protection from cell death. J. Biol. Chem 2001; 276: 36530-4. (Pubitemid 37384264)
10. Blackwell K, Zhang L, Thomas GS, Sun S, Nakano H, Habelhah H. TRAF2 phosphorylation modulates tumor necrosis factor α-induced gene expression and cell resistance to apoptosis. Mol. Cell Biol. 2009; 29: 303-14.
11. Habelhah H, Takahashi S, Cho SG, Kadoya T. Watanabe T, Ronai Z. Ubiquitination and translocation of TRAF2 is required for activation of JNK hut not of p38 or NF-κB. EMBO J. 2004; 23: 322-32. (Pubitemid 38294497)
12. Li S, Wang L, Berman MA, Zhang Y, Dorf ME. RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-κB signaling. Mol. Cell 2006; 24: 497-509. (Pubitemid 350284222)
13. Horie R, Watanabe T, Ito K. et al. Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells. Am J. Pathol 2002; 160: 1647-54. (Pubitemid 34525645)
14. Sakon S, Xue X, Takekawa M. et al. NF-κB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J. 2003; 22: 3898-909. (Pubitemid 36975716)
15. Moscat J, Diaz-Meco MT, Rennert P. NF-κB activation by protein kinase C isoforms and B-cell function. EMBO Rep 2003; 4: 31-6. (Pubitemid 36305374)
16. Moscat J, Rennert P, Diaz-Meco MT. PKCζ at the crossroad of NF-κB and Jakl/Stat6 signaling pathways. Cell Death Differ 2006; 13: 702-11.
17. Tan SL, Parker PJ. Emerging and diverse roles of protein kinase C in immune cell signalling. Biochem J. 2003; 376: 545-52. (Pubitemid 38058054)
18. Jaken S, Parker PJ. Protein kinase C binding partners. BioEssays 2000; 22: 245-54. (Pubitemid 30144417)
19. Schechtman D, Mochly-Rosen D. Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 2001; 20: 6339-47. (Pubitemid 32977843)
20. Lallena MJ, Diaz-Meco MT, Bren G, Paya CV, Moscat J. Activation of IκB kinase β by protein kinase C isoforms. Mol. Cell Biol. 1999; 19: 2180-8. (Pubitemid 29098275)
21. Rahman A, Anwar KM, Malik AB. Protein kinase C-ζ mediates TNF-α-induced ICAM-1 gene transcription in endothelial cells. Am J. Physiol Cell Physiol 2000; 279: C906-14.
22. Esteve PO, Chicoine E, Rohledo O. et al. Protein kinase C-ζ regulates transcription of the matrix met al.-loproteinase-9 gene induced by IL-1 and TNF-α in glioma cells via NF-κB. J. Biol. Chem 2002; 277: 35150-5.
23. Leitges M, Sanz L, Martin P. et al. Targeted disruption of the ζPKC gene results in the impairment of the NF-κB pathway. Mol. Cell 2001; 8: 771-80. (Pubitemid 33030211)
24. Chen ZJ. Uhiquitin signalling in the NF-κB pathway. Nat Cell Biol. 2005; 7: 758-65.
25. Barradas M, Monjas A, Diaz-Meco MT, Serrano M, Moscat J. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression. EMBO J. 1999; 18: 6362-9. (Pubitemid 29533240)
26. Cohen EE, Lingen MW, Zhu B. et al. Protein kinase C ζ mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cancer Res 2006; 66: 6296-303.